欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1590/001
药品名称
Ácido ibandrónico Aurovitas
活性成分
ibandronic acid 50.0 mg
剂型
Film-coated tablet
上市许可持有人
Aurovitas Unipessoal, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
许可日期
2016/11/16
最近更新日期
2024/01/02
药物ATC编码
M05BA06 ibandronic acid
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
PubAR
|
1590_Acido_Ibandronico_Ritisca_Summary_PAR_Scientific_PAR_07ABR2017_IRS
Date of last change:2024/09/06
Final Product Information
|
Ibandronic Acid Ritisca 150 mg_Labelling
Date of last change:2024/09/06
Final Product Information
|
Ibandronic Acid Ritisca 150 mg_PIL
Date of last change:2024/09/06
Final Product Information
|
Ibandronic Acid Ritisca 150 mg_SPC
Date of last change:2024/09/06
Final Product Information
|
Ibandronic Acid Ritisca 50 mg_Labelling text
Date of last change:2024/09/06
Final Product Information
|
Ibandronic Acid Ritisca 50 mg_PIL
Date of last change:2024/09/06
Final Product Information
|
Ibandronic Acid Ritisca 50 mg_SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase